Eir Pharma ApS: Financial statements 2025
CVR: 44476533
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Eir Pharma ApS (CVR 44476533) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -333,770 and a net result of DKK -361,247 compared with DKK -26,791 the year before. Equity in the 2025 report amounted to DKK -348,038.
- Gross Profit
- DKK -333,770
- Profit/Loss
- DKK -361,247
- Equity
- DKK -348,038
- Total Assets
- DKK 257,003
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -334 t. | -361 t. | -348 t. | 0 |
| 2024 | - | -26 t. | -27 t. | 13 t. | 0 |
How creditworthy is Eir Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Eir Pharma ApS has published its annual report for 2024. Gross profit came to DKK -25,687, and the net result was DKK -26,791.
About Eir Pharma ApS
Eir Pharma ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2023. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Sana Pharma Danmark ApS. The management consists of Heidi Tveit. The company is owned by Sana Pharma Medical ApS. In 2025, the company reported a gross profit of DKK -333,770 and a net result of DKK -361,247 compared with DKK -26,791 the year before. Equity in the 2025 report amounted to DKK -348,038.